Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Signs Group Purchasing Deal with Premier

NEW YORK (GenomeWeb News) – Cepheid said today that it has signed a group purchasing contract with Premier, a group purchasing organization that has more than 1,500 hospitals in its network.
 
The Sunnyvale, Calif.-based molecular diagnostics firm also said that it has signed a preferred vendor pact with the Western North Carolina Health Network. The WNCHN includes 53 acute care hospitals that use Premier as their GPO.
 
According to Cepheid, the agreements will enable Premier and WNCHN customers to purchase the firm’s GeneXpert multiplex platform and Xpert methicilllin-resistant Staphylococcus aureus tests at pre-negotiated prices.
 
Further details were not disclosed.
 
Cepheid's revenues have been increasingly shifting to the general hospital market, after its initial revenue base was built on sales to the Veterans Administration network of hospitals. Two weeks ago, the firm reported first-quarter revenue growth of 76 percent.
 

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.